Skip to main content
. Author manuscript; available in PMC: 2022 Apr 13.
Published in final edited form as: J Am Coll Cardiol. 2021 Apr 13;77(14):1778–1798. doi: 10.1016/j.jacc.2021.02.026

Figure 9. Maternal and Fetal Factors to Consider in the Management of Prosthetic Valves in Pregnant Women.

Figure 9.

Maternal physiologic changes must be considered in addition to fetal risks of warfarin exposure when considering optimal medication choice and dosing for women requiring anticoagulation during pregnancy. VKA – Vitamin K Antagonists.